0.00Open0.00Pre Close0 Volume0 Open Interest60.00Strike Price0.00Turnover0.00%IV-42.32%PremiumJul 5, 2024Expiry Date44.02Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.36Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Abbott Laboratories Stock Discussion
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
Gapping up
$United Airlines(UAL.US)$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US)$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
Read more here: Abbott Shares Slip as First-Quarter Earnings Outlook Misses Estimates
No comment yet